71125-44-5 Usage
Uses
Used in Pharmaceutical Industry:
5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE is used as a potential therapeutic agent for the treatment of various diseases due to its diverse biological activities and unique chemical structure. Its heterocyclic nature may contribute to its interaction with biological targets, offering opportunities for the development of new drugs.
The specific applications and reasons for the use of 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE in the pharmaceutical industry are not detailed in the provided materials. However, given its potential biological activities, it may be utilized in the following ways:
As a lead compound in drug discovery for targeting specific diseases or conditions.
For the development of new pharmaceuticals with novel mechanisms of action.
In the synthesis of derivative compounds to enhance pharmacological properties such as potency, selectivity, and bioavailability.
Further research is necessary to determine the exact applications and therapeutic uses of 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE, as well as to evaluate its safety and efficacy in clinical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 71125-44-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,1,2 and 5 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 71125-44:
(7*7)+(6*1)+(5*1)+(4*2)+(3*5)+(2*4)+(1*4)=95
95 % 10 = 5
So 71125-44-5 is a valid CAS Registry Number.
71125-44-5Relevant academic research and scientific papers
1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS
-
, (2008/06/13)
The present invention presents novel 1,3,4-thiadiazole derivatives of formula I which have useful antiviral activity against herpes virus, cytomegalovirus (CMV).
1,3,4-thiadiazoles useful for the treatment of CMV infections
-
, (2008/06/13)
The present invention presents novel 1,3,4-thiadiazole derivatives of formula I which have useful antiviral activity against herpes virus, cytomegalovirus (CMV).
7H-1,3,4-Thiadiazolo-[3,2-a]-pyrimidin-7-one-5-carboxylic compounds
-
, (2008/06/13)
Derivatives of 7H-1,3,4-thiadiazolo-[3,2-a]-pyrimidin-7-one-5-carboxylic acid having basic substituents in the 2-position, the alkyl esters and/or pharmaceutically useable salts of these compounds are new substances having immunstimulating properties, being especially valuable for antiinfectious therapy in mammals including man. The new products are prepared by reacting 2-amino-5-(basically substituted)-1,3,4-thiadiazoles with dialkylacetylenedicarboxylates and splitting the ester grouping in the obtained compound if desired and/or forming pharmaceutically acceptable salts.